Abstract:AIM:To study Hepatitis B virus (HBV) infection and its association with hepatocellular carcinoma (HCC) at the miRNA level.METHODS:Three cellular models were used to investigate miRNA expression changes during HBV infection: human HepG2 hepatoblastoma cell line as a model without HBV infection; HepG2 cell line transfected with a 1.3-fold full-length HBV genome as an acute infection model; and HepG2.2.15 cell line, which is derived from HepG2 and stably transfected with a complete HBV genome, as a chronic infection model. The miRNA levels were examined using microarray technology. To explore the relationship between HBV infection and HCC genesis at the miRNA level, we downloaded from national center for biotechnology information Gene Expression Omnibus an miRNA expression dataset derived from HCC patients, most of whom are HBV carriers. We compared the miRNA expression alterations during HBV infection with those in HCC patients, by analyzing miRNA expression change profiles statistically.RESULTS:Seventy-seven and 48 miRNAs were differentially expressed during acute and chronic HBV infection, respectively. Among these miRNAs, 25 were in common, the intersection of which was significant under the hypergeometric test (P = 1.3 × 10⁻¹¹). Fourteen miRNAs were observed to change coherently in the acute and chronic infections, with one upregulated and 13 downregulated. Eleven showed inverse changes during the two phases of infection; downregulated in the acute infection and upregulated in the chronic infection. The results imply that common and specific mechanisms exist at the miRNA level during acute and chronic HBV infection. Besides, comparative analysis of the miRNA expression changes during HBV infection with those in HCC indicates that, although miRNA expression changes during HBV infection are distinct from those in HCC patients (P < 2.2 × 10⁻¹⁶), they exhibited significant correlations (P = 0.0229 for acute infection; P = 0.0084 for chronic infection). Perturbation of miRNA expression during chronic HBV infection was closer to that in HCC patients than that during acute HBV infection. This observation implies the contribution of miRNAs to HCC genesis from HBV infection. According to their patterns of differential expression in acute and chronic HBV infection, as well as in HCC, miRNAs of potential research interest could be identified, such as miR-18a/miR-18b, miR-106a, miR-221 and miR-101. For instance, the gradient expression alteration of miR-221 in the above three phases, which is downregulated in acute HBV infection, normally expressed in chronic HBV infection, and upregulated in HCC, indicates that it may be a key effector for progression of the disease.CONCLUSION:Our analysis provides insights into HBV infection and related HCC in relation to miRNAs, and reveals some candidate miRNAs for future studies.

The Hepatitis B Virus-Associated Estrogen Receptor Alpha (eralpha) Was Regulated by Microrna-130A in HepG2.2.15 Human Hepatocellular Carcinoma Cells.

Estrogen Receptor Α Represses Transcription of HBV Genes Via Interaction with Hepatocyte Nuclear Factor 4Α.

Mir-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males

MicroRNA Profile in HBV-induced Infection and Hepatocellular Carcinoma.

Hepatitis B Virus X Protein and the Estrogen Receptor Variant Lacking Exon 5 Inhibit Estrogen Receptor Signaling in Hepatoma Cells.

Mir-130A-3p Promotes Cell Proliferation and Invasion by Targeting Estrogen Receptor Α and Androgen Receptor in Cervical Cancer.

Hepatitis B Virus and Hepatocellular Carcinoma at the Mirna Level.

Expression of estrogen receptor α in hepatitis B-related hepatocellular carcinoma and its clinical significance]

Influence of Mir-520E-mediated MAPK Signaling Pathway on HBV Replication and Regulation of Hepatocellular Carcinoma Cells Via Targeting EphA2

Up-regulated Expression of Mir-181A in HepG2.2.15 Cells Transfected Via Full-Length Hepatitis B Virus Genome

Microrna-602 Regulating Tumor Suppressive Gene Rassf1a is Overexpressed in Hepatitis B Virus-Infected Liver and Hepatocellular Carcinoma

Hepatitis B Virus X Protein Induces Expression Changes of miR-21, miR-22, miR-122, miR-132, and miR-222 in Huh-7 Cell Line

Up-regulated MicroRNA-181a Induces Carcinogenesis in Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting E2F5

Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma

Hepatitis B Viral RNA Directly Mediates Down-regulation of the Tumor Suppressor MicroRNA miR-15a/miR-16-1 in Hepatocytes

Retraction Note: HBx/ERα Complex-Mediated LINC01352 Downregulation Promotes HBV-related Hepatocellular Carcinoma Via the Mir-135B-apc Axis.

MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B.

[The Expression and Clinopathological Significance of Mir-130B in Human Hepatocellular Carcinoma].

Hepatitis B Virus Inhibits Apoptosis of Hepatoma Cells by Sponging the MicroRNA 15a/16 Cluster

Mir-197 Expression in Peripheral Blood Mononuclear Cells from Hepatitis B Virus-Infected Patients.

ERa-36 Instead of ERa Mediates the Stimulatory Effects of Estrogen on the Expression of Viral Oncogenes HPV E6/E7 and the Malignant Phenotypes in Cervical Cancer Cells.